Why the study?
Does the systemic inflammatory response index (SIRI) predict MACE and provide incremental prognostic value in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Population
Patients with ACS undergoing percutaneous coronary intervention
Authors
Loading...
May refine ACS-PCI risk stratification beyond GRACE; leaves open prospective validation before clinical adoption.
Does the systemic inflammatory response index (SIRI) predict MACE and provide incremental prognostic value in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
The systemic inflammatory response index (SIRI) is an independent predictor of MACE that provides incremental prognostic value beyond the GRACE risk score in ACS patients undergoing PCI.
Han et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: